A prospective pilot study investigating the effect of Autologous Tenocyte Implantation on gluteal tendinopathy

Not Applicable

• Conditions: Gluteal Tendinopathy; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12612000383864
• Lead Sponsor: Orthocell

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-04-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Gluteal tendinopathy, with or without partial tears.
Failure of normal conservative treatments

Exclusion Criteria

Previous surgery
Full thickness gluteal tendon tears
Hip osteoarthritis
Active infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual analogue pain scores[3,6, 12 and 24 months];Oxford Hip scores<br>The Oxford hip score is a validated self reported questionnaire that measures symptoms arising from the hip joint. It consists of 12 questions that are have responses scored from 1 to 5. For example: How would you describe the pain you usually have from your hip?[3, 6, 12 and 24 months];SF-36<br>The improvement in physical health and mental health as measured by the SF-36 health survey.[3,6, 12 and 24 months]

Secondary Outcome Measures

Name	Time	Method
MRI scan<br>The changes in appearance of the gluteal tendons on MRI scan following tenocyte injection. The scans will be reported by an independent radiologist.[6 months]